ICD Device Assistance in Diagnosis and Management of Atrial Tachyarrhythmia by Manolis, Antonis S et al.
ICD Device Assistance in Diagnosis and 
Management of Atrial Tachyarrhythmia
Antonis S. Manolis, MD, Anastasiος Koumoulidis, MD,  
Prokopis Papadimitriou, MD, Nikolaos Sakellaris, MD
A b s t r A c t
An implanted cardiac resynchronization and defibrillator device was helpful in clari-
fying the diagnosis of atrial tachyarrhythmia and cardioverting the arrhythmia, and 
thus restoring atrio-biventricular synchrony, followed by quick response to pharmaco-
therapy and stabilization of a patient with acute exacerbation of heart failure.
A 75-year-old gentleman with ischemic cardiomyopathy and severe left ventricular 
dysfunction, fitted with a cardiac resynchronization therapy (CRT) device (biventricular 
cardioverter defibrillator / CRT-D device), presented with acute decompensation of 
heart failure three days before Christmas. A 12-lead electrocardiogram (ECG) initially 
showed a mostly regular rhythm at 95 bpm without apparent pacing except for an 
occasional beat (Figure, Panel A). He was treated with intravenous furosemide and 
metolazone, infusion of dobutamine, increase in the dosage of carvedilol and a bolus 
of digoxin; he continued receiving his regular doses of eplererone, irbesartan, ami-
odarone, and acenocoumarol. A repeat ECG showed a paced rhythm at the previously 
programmed lower rate limit of 85 bpm with not clearly discernible P waves (Panel 
B). The next day the patient’s device was interrogated via the external programmer, 
which displayed the intracardiac electrograms (IEGMs) confirming a diagnosis of 
atrial flutter (Panel C; asterisks indicate the atrial electrograms- F or flutter waves). 
Subsequent attempt of conversion of the arrhythmia by overdrive pacing via the device 
led to degeneration into atrial fibrillation (Panel D; thin arrows point to the f waves), 
which, with the delivery of 30 joules through the CRT-D device (Panel D, thick arrow), 
was finally cardioverted into an atrio-biventricular paced rhythm (Panels E and F). 
Following this intervention, which restored both atrio-ventricular and intra-ventricular 
synchrony, the patient showed signs of rapid response to anti-congestive therapy with 
considerable amelioration of the respiratory, hemodynamic and clinical status. He had 
an increased diuresis with subsiding fluid retention and edema with resultant weight 
loss, was weaned off inotropic therapy, and had a remarkable and swift recovery allow-
ing him to get discharged home the next day (Christmas Eve), just in time to celebrate 
Christmas at home with his family.
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AbbreviAtions
AF = atrial fribrillation
AFlu = atrial flutter
CRT = cardiac resynchronization therapy
CRT-D = cardiac resynchronization 
therapy-defibrillator (device)
ECG = electrocardiogram
ICD = implantable cardioverter 
defibrillator
40
HOSPITAL CHRONICLES 9(1), 2014
●●●
Atrial tachyarrhythmias, comprising atrial flutter (AFlu) 
and atrial fibrillation (AF), are particularly common in pa-
tients with left ventricular dysfunction and heart failure and 
their prevalence depends on the degree and severity of the 
underlying cardiac pathology, ranging from 10%-20% in mild 
to moderate heart failure to 40-50% in patients with more 
advanced disease.1 Approximately one quarter of patients who 
receive an implantable cardioverter defibrillator (ICD) device 
have documented atrial tachyarrhythmias before implantation, 
while a large proportion of patients without prior history of 
atrial tachyarrhythmias will develop these arrhythmias after 
ICD implantation. Cardiac resynchronization therapy (CRT), 
effected via biventricular pacing usually combined with an ICD 
(CRT-D device), has emerged as an important and established 
therapy for patients with drug refractory heart failure due to 
systolic dysfunction (left ventricular ejection fraction <35%) 
and with cardiac dyssynchrony present in patients with a 
prolonged QRS complex, mainly in the form of left bundle 
branch block.2 Similar to patients with ICDs, atrial tachyar-
rhythmias may complicate the course of up to 40% of patients 
with CRT-D devices.2
Management of atrial tachyarrhythmias in patients with 
ICDs or CRT-D devices is important because of the signifi-
cant associated independent risk of increased morbidity and 
mortality and the increased cost of medical care conferred by 
the occurrence of these arrhythmias. Aside from loss of atrio-
ventricular coordination, the main problem that AF or AFlu 
produce is a fast ventricular response that exceeds the pacing 
rate, leading to loss of or poor response to CRT, and also to 
delivery of inappropriate ICD shocks if the ventricular rate is 
very rapid, while fast tracking of the arrhythmia by the device 
further exacerbates heart failure.2
External cardioversion has long been a cause of concern 
regarding the potential adverse effects on the device generator 
and on the leads induced by the electrical shocks.3 However, 
in a patient with an ICD or CRT-D device needing cardiover-
sion, the shock can be delivered using the implanted device 
rather than the external defibrillator.4 The benefit of using 
the internal device is that it avoids the risk of a skin irrita-
tion from an external shock and averts possible damage to 
the implanted system from the shock. The drawback of using 
the internal device is that it drains some of the battery in the 
device and may not always be effective in cardioverting atrial 
tachyarrhythmias. 
In the present case, the device was also very useful in 
rendering the correct diagnosis, allowing to apply overdrive 
pacing therapy,5,6 albeit it did not work in this case, and finally 
delivering effective internal electrical cardioversion. The en-
suing restoration of atrio-biventricular synchrony led to an 
enhanced and remarkable response to anti-congestive therapy 
in this patient and an expeditious discharge from the hospital, 
further curtailing medical cost. 
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